Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Receivables - Other (2016 - 2022)

Historic Receivables - Other for Rockwell Medical (RMTI) over the last 8 years, with Q3 2022 value amounting to $7.4 million.

  • Rockwell Medical's Receivables - Other rose 2205.1% to $7.4 million in Q3 2022 from the same period last year, while for Sep 2022 it was $7.4 million, marking a year-over-year increase of 2205.1%. This contributed to the annual value of $5.9 million for FY2021, which is 4176.46% up from last year.
  • Per Rockwell Medical's latest filing, its Receivables - Other stood at $7.4 million for Q3 2022, which was up 2205.1% from $8.1 million recorded in Q2 2022.
  • In the past 5 years, Rockwell Medical's Receivables - Other ranged from a high of $8.1 million in Q2 2022 and a low of $5122.0 during Q3 2019
  • For the 5-year period, Rockwell Medical's Receivables - Other averaged around $4.3 million, with its median value being $4.6 million (2020).
  • Its Receivables - Other has fluctuated over the past 5 years, first tumbled by 9993.25% in 2019, then soared by 8051304.18% in 2020.
  • Rockwell Medical's Receivables - Other (Quarter) stood at $371217.0 in 2018, then skyrocketed by 1032.22% to $4.2 million in 2019, then dropped by 0.76% to $4.2 million in 2020, then soared by 41.76% to $5.9 million in 2021, then grew by 24.59% to $7.4 million in 2022.
  • Its Receivables - Other stands at $7.4 million for Q3 2022, versus $8.1 million for Q2 2022 and $7.1 million for Q1 2022.